Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells
- 28 June 1994
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 96 (3) , 508-512
- https://doi.org/10.1111/j.1365-2249.1994.tb06058.x
Abstract
SUMMARY: In order to assess the direct effects of cyclosporine A (CsA) and rapamycin on B cells, we utilized a two-segment culture system of highly purified B lymphocytes consisting of induction (activation) in the presence of the formalinized Staphylococcus aureus bacteria and IL-2. and differentiation, respectively, in the presence of various combinations of cytokines. Results show that rapamycin strongly inhibited production of both IgM and IgG measured at the end of the secondary culture supported by IL-2/IL-6, whereas CsA up-regulated the immunoglobulin production. The stimulatory effect of CsA was also observed when preactivated B cells were recultured in absence of any cytokines. These results show that rapamycin and CsA have dearly distinct effects on human B lymphocyte responses in vitro. Rapamycin is a more potent in vitro immunosuppressant of B lymphocytes than CsA. It is effective at significantly lower concentrations, and it does not stimulate either the proliferation or antibody production by preactivated B cells.Keywords
This publication has 18 references indexed in Scilit:
- Mechanisms of Action of Cyclosporine: Considerations for the Treatment of Autoimmune DiseasesClinical Immunology and Immunopathology, 1993
- INHIBITION OF IN VITRO IMMUNOGLOBULIN PRODUCTION BY RAPAMYCIN1Transplantation, 1992
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Chemistry and Biology of the Immunophilins and Their Immunosuppressive LigandsScience, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990
- POSSIBLE ASSOCIATION OF THE IMMUNOSUPPRESSIVE AND B CELL LYMPHOMA-PROMOTING PROPERTIES OF CYCLOSPORINETransplantation, 1990
- HIGH INCIDENCE OF MONOCLONAL IMMUNOGLOBULINS IN PATIENTS AFTER LIVER OR HEART TRANSPLANTATIONTransplantation, 1988
- Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen.Journal of Clinical Investigation, 1986
- Regulation of B-Cell Growth and Differentiation by Soluble FactorsAnnual Review of Immunology, 1983